Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Free Radic Res ; 48(8): 919-28, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24865925

ABSTRACT

Human oxidation resistance 1 (OXR1) functions in protection against oxidative damage and its homologs are highly conserved in eukaryotes examined so far, but its function still remains uncertain. In this study, we identified a homolog (LMD-3) of human OXR1 in the nematode Caenorhabditis elegans (C. elegans). The expressed LMD-3 was able to suppress the mutator phenotypes of E. coli mutMmutY and mutT mutants. Purified LMD-3 did not have enzymatic activity against 8-oxoG, superoxide dismutase (SOD), or catalase activities. Interestingly, the expression of LMD-3 was able to suppress the methyl viologen or menadione sodium bisulfite-induced expression of soxS and sodA genes in E. coli. The sensitivity of the C. elegans lmd-3 mutant to oxidative and heat stress was markedly higher than that of the wild-type strain N2. These results suggest that LMD-3 protects cells against oxidative stress. Furthermore, we found that the lifespan of the C. elegans lmd-3 mutant was significantly reduced compared with that of the N2, which was resulted from the acceleration of aging. We further examined the effects of deletions in other oxidative defense genes on the properties of the lmd-3 mutant. The deletion of sod-2 and sod-3, which are mitochondrial SODs, extended the lifespan of the lmd-3 mutant. These results indicate that, in cooperation with mitochondrial SODs, LMD-3 contributes to the protection against oxidative stress and aging in C. elegans.


Subject(s)
Aging/metabolism , Caenorhabditis elegans Proteins/metabolism , Mitochondrial Proteins/metabolism , Oxidative Stress/physiology , Animals , Caenorhabditis elegans , Reactive Oxygen Species/metabolism
3.
J Lipid Res ; 42(10): 1655-63, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11590222

ABSTRACT

Rats fed a semipurified diet supplemented with 3% (w/w) safflower oil [Saf, n-3 fatty acid deficient, high linoleic acid (18:2n-6)] through two generations exhibit decreased correct response ratios in a brightness-discrimination learning test compared with rats fed 3% perilla oil [Per, high alpha-linolenic acid (18:3n-3)]. This is associated with a decreased DHA (22:6n-3)-to-arachidonic acid (20:4n-6) ratio in brain lipids. In the first set of experiments, dietary oil was shifted from Saf to a mixture of 2.4% safflower oil plus 0.6% DHA after weaning (Saf-DHA), but all parameters measured in the learning test were essentially unchanged. Brain 22:6n-3 content of the Saf-DHA group reached that of the Per group but the levels of 20:4n-6 and docosatetraenoic acid (22:4n-6) did not decrease to those of the Per group at the start of the test. In the second set of experiments, dietary oil was shifted to a mixture of 0.6% safflower oil plus 1.2% oleic acid (OA) plus 1.2% DHA (Saf-OA-DHA group) with 18:2n-6 content comparable to that of the Per group. The Saf-OA-DHA group exhibited a learning performance similar to that of the Per group; brain 22:6n-3, 20:4n-6, and 22:4n-6 contents were also comparable to those of the Per group. These results indicate that the altered learning behavior associated with a long-term n-3 fatty acid deficiency is reversed by supplementing 22:6n-3 after weaning, when the levels of competing n-6 fatty acids in the diet and brain lipids are limited.


Subject(s)
Fatty Acids, Omega-3/pharmacology , Fatty Acids, Unsaturated/deficiency , Fatty Acids, Unsaturated/pharmacology , Learning/drug effects , Safflower Oil/pharmacology , Aging/physiology , Animals , Central Nervous System/chemistry , Central Nervous System/drug effects , Central Nervous System/metabolism , Dietary Fats, Unsaturated/administration & dosage , Dietary Fats, Unsaturated/pharmacology , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/pharmacology , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/analysis , Fatty Acids, Omega-6 , Fatty Acids, Unsaturated/administration & dosage , Fatty Acids, Unsaturated/analysis , Female , Light , Neuropsychological Tests , Photic Stimulation , Plant Oils , Rats , Reinforcement, Psychology , Safflower Oil/administration & dosage , Visual Perception/drug effects , Weaning , alpha-Linolenic Acid/administration & dosage , alpha-Linolenic Acid/pharmacology
4.
Antimicrob Agents Chemother ; 45(9): 2450-4, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11502513

ABSTRACT

beta-Lactams have been considered ineffective against organisms growing inside mammalian cells because of their poor penetration into cells. However, cefixime has been shown to be clinically effective against typhoid fever. The probable mechanism of therapeutic effectiveness of cefixime against typhoid fever was investigated using Salmonella enterica serovar Typhimurium instead of S. enterica serovar Typhi both in a cellular and in a mouse infection model. Cefixime was able to inhibit the growth of serovar Typhimurium inhabiting monocyte-derived THP-1 cells. Elongation of serovar Typhimurium in THP-1 cells was observed microscopically. Apparent morphological changes of serovar Typhimurium in THP-1 cells were also observed by electron microscopy. The concentration of cefixime inside THP-1 cells was almost half (46 to 48%) of the concentration outside the cells when serovar Typhimurium coexisted in the solution. The length of time after oral dosing (8 mg/kg) that cefixime was present-calculated from levels in serum-at a concentration above the MIC at which 90% of the serovar Typhi organisms inside human cells were inhibited was presumed to be more than 12 h. Cefixime also showed excellent activity in the mouse systemic and oral infection models based on infections caused by serovar Typhimurium. It is concluded that a fair amount of cefixime can enter mammalian cells and inhibit the growth of bacteria inside cells when the bacteria are sensitive enough to cefixime, as are serovars Typhimurium and Typhi.


Subject(s)
Cefixime/therapeutic use , Cephalosporins/therapeutic use , Salmonella Infections/drug therapy , Typhoid Fever/drug therapy , Animals , Cell Survival , Disease Models, Animal , Humans , Male , Mice , Mice, Inbred ICR , Microbial Sensitivity Tests , Salmonella/drug effects , Serotyping , Treatment Outcome , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/microbiology , Tumor Cells, Cultured/pathology
5.
Ann Neurol ; 50(1): 117-20, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11456301

ABSTRACT

We report a case of familial frontotemporal dementia and parkinsonism characterized by early onset with mental retardation. The patient died at the age of 54; neuronal loss was severe in the frontal and temporal cortices, globus pallidus, substantia nigra, red nucleus and dentate nucleus. Anti-tau-positive fibrillary changes were observed in neurons and glia in these regions. Although the patient had 2 novel point mutations of the tau gene, P301P (CCG to CCA) and an intron 10+11-splice site (T to C), exon trapping analysis indicated that the latter was pathogenic.


Subject(s)
Brain/pathology , Dementia/genetics , Dementia/pathology , Introns/genetics , Parkinsonian Disorders/genetics , Point Mutation/genetics , tau Proteins/genetics , Humans , Immunohistochemistry , Male , Middle Aged , Pedigree
6.
Virology ; 283(2): 315-23, 2001 May 10.
Article in English | MEDLINE | ID: mdl-11336556

ABSTRACT

Although acute infection of feline foamy virus (FeFV) is normally highly cytopathogenic in Crandell feline kidney (CRFK) cells, a noncytopathic persistent infection was established in the cells after cocultivation of the initially infected cells with uninfected cells four times. To investigate reactivation of persistent infection, CRFK cells chronically infected with FeFV were treated with trichostatin A (TA), a histone deacetylase inhibitor. TA induced higher FeFV production from the Coleman strain carrier culture and also induced marked syncytium formation. In contrast, human foamy virus, which contains less homologous long terminal repeat (LTR) and putative internal promoter (IP) sequences, persistently infecting baby hamster kidney cells was not reactivated by TA. The Sammy-1 strain of FeFV, from which a part of the U3 region in the LTR is naturally deleted, showed less reactivation. The Coleman LTR promoter-based beta-Gal-expressing plasmid was activated in the persistently Coleman-infected cells in the presence of TA, whereas the Sammy-1 LTR was not activated. Furthermore, the amounts of Gag protein expressed did not change in the presence or absence of TA. Because the putative IP region was very similar between the two strains, the initiation by TA is relatively specific for LTR sequences, and, therefore, histone deacetylation is at least in part responsible for reactivation of FeFV from carrier cell culture.


Subject(s)
Hydroxamic Acids/pharmacology , Spumavirus/physiology , Virus Activation/drug effects , Animals , Base Sequence , Cats , Cell Line , Gene Products, gag/genetics , Genome, Viral , Kidney , Molecular Sequence Data , Spumavirus/drug effects , Terminal Repeat Sequences/genetics
7.
Clin Neuropathol ; 20(1): 8-12, 2001.
Article in English | MEDLINE | ID: mdl-11220696

ABSTRACT

We report a patient with frontotemporal degeneration and parkinsonism with mental retardation. The patient was a 54-year-old man who had parkinsonism that resembled progressive supranuclear palsy, frontotemporal degeneration and myoclonus. His family included many affected members. Neuropathologically, there was degeneration of the frontal and temporal cortices, the basal ganglia, the brainstem and the cerebellum. Microscopically, neuronal loss was severe in the frontal and temporal cortex, the globus pallidus, substantia nigra, red nucleus and dentate nucleus. Fibrillary changes were found in neurons and glia that were immunostained for tau. Although we could not define the genetic abnormalities, we thought that this case might have involved frontotemporal dementia and parkinsonism linked to chromosome 17.


Subject(s)
Dementia/pathology , Parkinson Disease/pathology , Supranuclear Palsy, Progressive/pathology , Brain/pathology , Dementia/genetics , Family Health , Fatal Outcome , Humans , Male , Middle Aged , Parkinson Disease/genetics , Pedigree , Supranuclear Palsy, Progressive/genetics
8.
J Neurosci Res ; 63(2): 185-95, 2001 Jan 15.
Article in English | MEDLINE | ID: mdl-11169628

ABSTRACT

We have analyzed oligosaccharide chains in brain microsomes of rats fed an n-3 polyunsaturated fatty acid-deficient (safflower oil group; S group) or -rich (perilla oil group; P group) diet before and after brightness-discrimination learning tasks. The amount of concanavalin A-binding sites (mainly mannoside) of the brain microsomes was found to be significantly less in the S group than the P group before the learning task. Detailed analysis of glycoprotein glycans demonstrated that high mannose type oligosaccharides were dominant in brain microsomes before the learning task in both dietary groups, whereas multiantennary complex-type oligosaccharides became dominant after the learning task and especially a tetra-antennary glycan, that had a core structure of the glycan of neural cell adhesion molecule, was more increased in the S-group than the P group. When polysialylated glycans were analyzed on serotonin-conjugated HPLC column, the glycans in the S-group microsomes before the learning task contained larger amount of higher affinity-polysialylated glycans to serotonin column than those in the P-group, and also contained larger amount of phosphoglycans that showed also high affinity to serotonin column than the P-group. Removal of mannoside from microsomes by alpha-mannosidase-treatment changed the membrane surface physical property, especially permittivity, as revealed by analysis of the interaction with 1-anilinonaphthalene-8-sulfonate. These results suggest that high mannose content and several multiantennary glycans including polysialylated and phospho-glycans were changed by dietary n-3 fatty acid deficiency and learning task in rat brain microsomal glycoproteins and that these changes may affect membrane functions through changes of membrane surface physical properties and reactivity against serotonin.


Subject(s)
Brain/metabolism , Fatty Acids, Omega-3/metabolism , Food, Formulated/adverse effects , Learning/physiology , Microsomes/metabolism , Oligosaccharides/metabolism , Animals , Chromatography, High Pressure Liquid , Glycoproteins/metabolism , Learning Disabilities/metabolism , Learning Disabilities/physiopathology , Mannose/metabolism , Membrane Potentials/physiology , Phosphorylation , Rats , Receptors, Concanavalin A/metabolism , Sialic Acids/metabolism , Sialoglycoproteins/metabolism
9.
J Nutr Biochem ; 12(8): 474-480, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11834206

ABSTRACT

Female mice were fed a conventional diet, shifted at 119 days of age to a diet supplemented with 10 wt % lard (Lar), high-linoleic (n-6) safflower oil (Saf), rapeseed oil (low-erucic, Rap), high-alpha-linolenic (n-3) perilla oil (Per) or a mixture (1:9) of ethyl docosahexaenoate (n-3) and soybean oil (DHA/Soy). Weight gain was less in the Per group than in the other groups at 497 days of age. In the Rap group, proteinuria was more severe than in the Saf, Per and DHA/Soy group, and hepatic triacylglycerol accumulation was greater than in the other groups. The mean survival time of the DHA/Soy group (753 days) was significantly longer than in the Lar group (672 days) and Saf group (689 days); the differences among other groups (e.g., 701 days in the Per group and 712 days in the Rap group) were not statistically significant. Although DHA is more susceptible to auto-oxidation than other major fatty acids in the air, an oil containing DHA was found to increase the survival of mice. Rapeseed oil that decreases the survival time of SHRSP rats was found to be safe in the mouse strain used in this study when survival was an end point.

11.
J Nutr ; 130(12): 3059-62, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11110869

ABSTRACT

The retinal rod outer segment (ROS) is shed and digested daily by phagosomes in retinal pigment epithelial (RPE) cells. We previously observed significantly fewer large phagosomes in rats fed an alpha-linolenic acid (ALNA)-deficient diet. Rats fed a safflower oil diet (ALNA-restricted) or a perilla oil diet (ALNA-sufficient) through two generations were adapted to a 24-h cycle with light from 0700 to 1900 h. They were killed at 0500, 0900, 1300 and 1700 h to determine the activities of four lysosomal enzymes in retina, including beta-glucosidase, beta-glucuronidase, hexosaminidase and acid phosphatase. The enzyme activities at 0500 h were the lowest and then increased gradually until 1700 h, exhibiting similar circadian rhythms in the two dietary groups. However, the activities at each time point were significantly lower in the safflower group. In the pineal gland, the activities were maximum at 1300 h, except for beta-glucosidase, and were not different between groups. These diets had qualitatively similar but quantitatively different effects on the fatty acid compositions of the retina and the pineal gland. These results indicate that decreased amplitudes in electroretinogram and altered size distribution of phagosomes, as induced by a restricted intake of ALNA, are associated with decreased lysosomal enzyme activities in the retina but not in the pineal gland.


Subject(s)
Circadian Rhythm , Lysosomes/metabolism , Phagosomes/physiology , Pineal Gland/enzymology , Retina/enzymology , alpha-Linolenic Acid/administration & dosage , Acid Phosphatase/metabolism , Animals , Fatty Acids/analysis , Glucuronidase/metabolism , Hexosamines/metabolism , Pineal Gland/chemistry , Rats , Retina/chemistry , Time Factors , alpha-Linolenic Acid/deficiency , beta-Glucosidase/metabolism
12.
Lipids ; 35(10): 1107-15, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11104017

ABSTRACT

Docosahexaenoic acid (DHA, 22:6n-3) is one of the major polyunsaturated fatty acids esterified predominantly in aminophospholipids such as ethanolamine glycerophospholipid (EtnGpl) and serine glycerophospholipid (SerGpl) in the brain. Synaptosomes prepared from rats fed an n-3 fatty acid-deficient safflower oil (Saf) diet had significantly decreased 22:6n-3 content with a compensatory increased 22:5n-6 content when compared with rats fed an n-3 fatty acid-sufficient perilla oil (Per) diet. When the Saf group was shifted to a diet supplemented with safflower oil plus 22:6n-3 (Saf + DHA) after weaning, 22:6n-3 content was found to be restored to the level of the Per group. The uptake of [3H]ethanolamine and its conversion to [3H]EtnGpl did not differ significantly among the three dietary groups, whereas the formation of [3H]lysoEtnGpl from [3H]ethanolamine was significantly lower in the Saf group than in the other groups. The uptake of [3H]serine, its incorporation into [3H]SerGpl, and the conversion into [3H]EtnGpl by decarboxylation of [3H]SerGpl did not differ among the three dietary groups. The observed decrease in lysoEtnGpl formation associated with a reduction of 22:6n-3 content in rat brain synaptosomes by n-3 fatty acid deprivation may provide a clue to reveal biochemical bases for the dietary fatty acids-behavior link.


Subject(s)
Brain/metabolism , Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-3/physiology , Synaptosomes/metabolism , Animals , Dietary Fats/pharmacokinetics , Docosahexaenoic Acids/metabolism , Ethanolamine/pharmacokinetics , Female , Male , Rats , Rats, Wistar , Safflower Oil/pharmacology , Serine/pharmacokinetics , Time Factors
13.
Arch Biochem Biophys ; 383(1): 108-13, 2000 Nov 01.
Article in English | MEDLINE | ID: mdl-11097182

ABSTRACT

Rats fed a safflower oil (alpha-linolenic acid (ALNA)-deficient) diet over the course of two generations had significantly decreased docosahexaenoic acid (22:6n-3) and increased docosapentaenoic acid (22:5n-6) contents in the major retinal phospholipids such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS) when compared with those fed a perilla oil (ALNA-sufficient) diet, but the compositions of phosphatidylinositol acyl chains were relatively unaffected. The contents of individual phospholipids in the retina were essentially the same for the two dietary groups. The activities of the rate-limiting enzymes in the de novo synthesis of PC and PE, CTP:phosphocholine cytidylyltransferase (CT), and CTP:phosphoethanolamine cytidylyltransferase (ET), respectively, were measured in the retinas excised at 5:00, 9:00, 13:00, and 17:00 h from rats adapted to a 24-h cycle with lights on from 7:00 to 19:00 h. Both enzymes exhibited significant diurnal rhythms with the lowest activities at 5:00 h and gradually increasing activities following exposure of the rats to light; the maximum activities were at 13:00 h for CT and 17:00 h for ET. The diurnal rhythms were not significantly affected by the above-mentioned diets. However, both enzyme activities at each collection time point were significantly lower in the safflower oil group than in the perilla oil group. These results suggest that retinal phospholipid turnover associated with shedding, phagocytosis, and resynthesis of the rod outer segments is limited by ALNA deficiency.


Subject(s)
Phospholipids/biosynthesis , Retina/metabolism , alpha-Linolenic Acid/deficiency , Animals , Circadian Rhythm , Diet , Rats
15.
Neurosci Lett ; 285(2): 99-102, 2000 May 12.
Article in English | MEDLINE | ID: mdl-10793236

ABSTRACT

Dietary deprivation of alpha-linolenic acid (n-3) through two generations has been shown to lower performance in an operant-type brightness-discrimination learning test in rats. Here, we examined a possible correlation between nerve growth factor (NGF) content and n-3 fatty acid status in the brain. Female rats were fed a semipurified diet supplemented with safflower oil (n-3 fatty acid-deficient) and their offsprings were fed a diet supplemented with either 3% safflower oil (Saf group) or a mixture of 2.4% safflower oil plus 0.6% ethyl eicosapentaenoate (Saf+EPA group) after weaning. The brain docosahexaenoic acid (22:6n-3, DHA) content in the Saf group was less than half of that in the Per group fed a diet supplemented with 3% perilla oil (n-3 fatty acid-sufficient) throughout the duration of the experiment. The DHA level of the Saf+EPA group was restored to the level of the Per group. However, the NGF contents in the hippocampus of the Saf and Saf+EPA groups were half that of the Per group. In the piriform cortex, the NGF content tended to be higher in the Saf and Saf+EPA groups than in the Per group. These results indicate that dietary n-3 fatty acid deficiency and restoration affect NGF levels differently among different brain regions.


Subject(s)
Dietary Fats/administration & dosage , Fatty Acids, Omega-3/metabolism , Hippocampus/metabolism , Nerve Growth Factor/metabolism , Animals , Dietary Fats/analysis , Fatty Acids, Essential/analysis , Fatty Acids, Essential/deficiency , Fatty Acids, Essential/physiology , Fatty Acids, Omega-3/analysis , Fatty Acids, Omega-3/physiology , Female , Hippocampus/chemistry , Nerve Growth Factor/analysis , Nerve Growth Factor/deficiency , Nerve Growth Factor/physiology , Rats , Rats, Inbred Strains
16.
Neurochem Res ; 25(2): 293-301, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10786715

ABSTRACT

Neurite elongation involves the expansion of the plasma membrane and phospholipid synthesis. We investigated membrane phosphatidylethanolamine (PE) biosynthesis in PC12 cells during neurite outgrowth induced by nerve growth factor (NGF). When PE was prelabeled with [3H]ethanolamine and the radioactivity was chased by incubation with 1 mM unlabeled ethanolamine, the radioactivity of [3H]PE steadily declined and [3H]ethanolamine was released into the medium in NGF-treated cells during neurite outgrowth; in the absence of unlabeled ethanolamine, the radioactivity of [3H]PE remained relatively constant for at least 24 hr. In undifferentiated cells but not in NGF-treated cells, [3H]phosphoethanolamine accumulated in significant amounts during pulse labeling, and was converted partly to PE but largely released into the medium irrespective of incubation with unlabeled ethanolamine. The decline in the radioactivity of [3H]PE and release of [3H]ethanolamine following incubation with unlabeled ethanolamine were also observed in undifferentiated cells. Thus, the ethanolamine moiety of PE derived from ethanolamine is actively recycled in both differentiated and undifferentiated cells. When PE was derived from [3H]serine through phosphatidylserine (PS) decarboxylation, the decrease in radioactivity of [3H]PE and release of [3H]ethanolamine into the medium following incubation with unlabeled ethanolamine were observed only in NGF-treated cells, but not in undifferentiated cells, indicating that the ethanolamine moiety of PE derived from PS is actively recycled only in the cells undergoing NGF-induced neuritogenesis. Thus, in PC12 cells, the ethanolamine moiety of PE derived from PS is regulated differently from that of PE derived from ethanolamine.


Subject(s)
Ethanolamine/metabolism , Nerve Growth Factor/pharmacology , Neurites , Phosphatidylethanolamines/metabolism , Serine/metabolism , Animals , Mice , PC12 Cells , Rats , Tritium
17.
Article in English | MEDLINE | ID: mdl-11467056

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is classified into distinct subtypes mainly based on clinicopathological features, in addition to epidemiologic and genetic backgrounds. In addition to sporadic ALS with classical pathology, characteristics in the clinical features, in the histological findings and their topographical distribution, and in the molecular pathology, especially the intracytoplasmic neuronal inclusions, enable us to identify the following subtypes: ALS with dementia (ALS-D), ALS in the Western Pacific, ALS with multi-system degeneration, familial ALS, and superoxide dismutase 1-linked ALS. These subtypes not infrequently exhibit various types of extra-motor system degeneration, and even multi-system pathology. Some of the subtypes (for instance ALS-D or familial ALS) can be deduced, to a certain extent, from characteristic neuronal inclusions such as ALS-type ubiquitinated inclusions, Lewy body-like hyaline inclusions (LBHIs), or ubiquitinated intracytoplasmic neuronal inclusions as typically seen in the dentate fascia. The purpose of this article is to clarify the molecular pathogenesis of the cerebral cortex in ALS-D and Guamanian ALS and parkinsonism-dementia complex (PDC), in order to elucidate the relationship and distinction between these two subtypes. As indicated previously, investigations on ubiquitin-immunoreactivity in the hippocampus further support the view that the pathology of G-ALS/PDC may be that of a tau-related tangle disorder, whilst ALS-D has a feature of the motor neuron disease type-frontotemporal dementia.


Subject(s)
Amyotrophic Lateral Sclerosis/pathology , Dementia/pathology , Motor Neurons/pathology , Diagnosis, Differential , Humans , Inclusion Bodies/pathology
18.
Acta Neuropathol ; 98(4): 367-73, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10502042

ABSTRACT

This study examined axonal terminal alterations in the anterior horn of amyotrophic lateral sclerosis (ALS) patients. An antibody against growth-associated protein 43 (GAP43), a phosphoprotein which is expressed in elongating terminals of neurites, was employed for immunohistochemical staining. Lumbar spinal cords taken at autopsy from five ALS patients and from six control adults were examined. In control patients, there were numerous GAP43-positive granules diffusely dispersed throughout the anterior horn neuropil, and individual large anterior horn cells (AHCs) showed numerous tiny immunoreactive granules and small dots on the surface. A small number of AHCs showed dense accumulation of GAP43 immunoreactivity on the surface of the cell body and proximal processes. In all ALS patients, similar accumulation of GAP43 immunoreactivity was seen on the surface of a large number of remaining AHCs. Statistical analysis revealed a significant increase in number of AHCs with such accumulation in ALS patients. These results suggest that during the ALS disease process there may be plastic alterations or a compensatory mechanism of the axonal terminals located on the surface of some AHCs for ongoing anterior horn presynaptic terminal degeneration.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Anterior Horn Cells/metabolism , GAP-43 Protein/biosynthesis , Membrane Proteins/biosynthesis , Adult , Aged , Aged, 80 and over , Amyotrophic Lateral Sclerosis/pathology , Anterior Horn Cells/pathology , Female , Humans , Immunohistochemistry , Male , Middle Aged , Motor Neurons/metabolism , Motor Neurons/pathology , Nerve Degeneration/metabolism , Nerve Degeneration/pathology , Presynaptic Terminals/metabolism , Presynaptic Terminals/pathology , Spinal Cord/pathology , Synapses/metabolism , Synapses/pathology
19.
Biol Pharm Bull ; 22(8): 775-9, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10480312

ABSTRACT

The influence of long-term n-3 fatty acid deficiency on the rate of protein synthesis in rat brain and liver was investigated in relation to learning behavior or a presumed survival time-shortening factor (SSF) in rapeseed oil, using a large-dose [3H]phenylalanine (Phe) injection method. When Wistar rats were made n-3 fatty acid-deficient by feeding a safflower oil (alpha-linolenate-deficient) diet for 2 generations, conditions under which the safflower oil group had been shown to exhibit altered learning behaviors, compared with the perilla oil group, no significant changes in the rate of protein synthesis were observed compared with the perilla oil (alpha-linolenate-sufficient) or rapeseed oil (alpha-linolenate-sufficient but SSF-containing) groups. However, the rapeseed oil group had a reduced specific radioactivity of free Phe in the cerebral cortex, compared with the safflower oil group. In contrast to the reported observation of very long-term n-3 fatty acid deficiency inducing an almost 2-fold increase in the rate of protein synthesis in the brain, our results indicate that altered learning behavior resulting from n-3 fatty acid deficiency in rats is not associated with any substantial changes in the rate of protein synthesis in the brain.


Subject(s)
Brain/metabolism , Fatty Acids, Omega-3/metabolism , Liver/metabolism , Protein Biosynthesis , Animals , Female , Kinetics , Plant Oils/administration & dosage , Rats , Rats, Wistar , alpha-Linolenic Acid/administration & dosage
20.
Arch Biochem Biophys ; 364(1): 67-74, 1999 Apr 01.
Article in English | MEDLINE | ID: mdl-10087166

ABSTRACT

We have shown previously that docosahexaenoic acid (DHA) promotes and arachidonic acid (AA) suppresses neurite outgrowth of PC12 cells induced by nerve growth factor (NGF) and that incorporation of [3H]ethanolamine into phosphatidylethanolamine (PE) is suppressed in PC12 cells by AA while DHA has no effect. In the present study, the effects of these fatty acids on PE synthesis via decarboxylation of phosphatidylserine (PS), another pathway of PE synthesis, and distribution of aminophospholipids were examined. Incorporation of [3H]serine into PS and PE was elevated in the course of NGF-induced differentiation and was further stimulated significantly by DHA, but not by AA. [3H]Ethanolamine uptake by PC12 cells was significantly suppressed by AA but not by DHA while these fatty acids did not affect [3H]serine uptake, indicating that the suppression by AA of [3H]ethanolamine incorporation into phosphatidylethanolamine is attributable, at least in part, to a reduction in [3H]ethanolamine uptake. The distribution of PE in the outer leaflet of plasma membrane decreased during differentiation, which is known to be accompanied by an increase in the surface area of plasma membrane. Supplementation of PC12 cells with DHA or AA did not affect the distribution of aminophospholipids. Thus, DHA and AA affected aminophospholipid synthesis and neurite outgrowth differently, but not the transport and distribution of aminophospholipids, while the PE concentration in the outer leaflet of the plasma membrane decreased in association with morphological changes in PC12 cells induced by NGF.


Subject(s)
Arachidonic Acid/pharmacology , Docosahexaenoic Acids/pharmacology , Neurons/metabolism , Peptides , Phospholipids/metabolism , Animals , Anti-Bacterial Agents/metabolism , Cell Differentiation , Cell Membrane/metabolism , Cell Size/drug effects , Ethanolamine/metabolism , Flow Cytometry , Hemolysin Proteins/metabolism , Nerve Growth Factors/pharmacology , Neurons/drug effects , PC12 Cells , Peptides, Cyclic , Phosphatidylethanolamines/metabolism , Phosphatidylserines/metabolism , Rats , Serine/metabolism , Trinitrobenzenesulfonic Acid/metabolism , Tritium
SELECTION OF CITATIONS
SEARCH DETAIL
...